In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C‐reactive protein?

Documenti analoghi

• Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank
  di: Qiaoling Liu, et al.
  Pubblicazione: (2024)
• Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people
  di: Sabrina Scilletta, et al.
  Pubblicazione: (2025)
• How would the use of Semaglutide impact the Chilean population? An estimated analysis following the SELECT trial approach
  di: Fanny Petermann‐Rocha, et al.
  Pubblicazione: (2025)
• The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
  di: Iskandar Idris, et al.
  Pubblicazione: (2025)
• When can weekly anti‐obesity peptides be used for monthly administration?
  di: Daniel V. Santi
  Pubblicazione: (2024)